The Cytosolic NADPH Oxidase Subunit NoxO1 Promotes an Endothelial Stalk Cell Phenotype

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 8, 2016, Pages 1558-1565

  Brandes, Ralf P ^a,e   Harenkamp, Sabine ^a   Schürmann, Christoph ^a,e   Josipovic, Ivana ^a,e   Rashid, Beliza ^a   Rezende, Flavia ^a,e   Löwe, Oliver ^a,e   Moll, Franziska ^a,e   Epah, Jeremy ^a,b   Eresch, Jeanette ^a   Nayak, Arnab ^b   Kopaliani, Irakli ^c   Penski, Cornelia ^b   Mittelbronn, Michel ^b   Weissmann, Norbert ^d   Schröder, Katrin ^a,e  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

ADAM17 protein; angiogenesis effect; dibenzazepine; Notch; NoxO1 protein, mouse; reactive oxygen species

Indexed keywords

ALPHA SECRETASE; LIGAND; NADPH OXIDASE ORGANIZER 1; NOTCH RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; ADAM10 ENDOPEPTIDASE; ADAM10 PROTEIN, MOUSE; ADAM17 PROTEIN, MOUSE; MEMBRANE PROTEIN; NEUTROPHIL CYTOSOLIC FACTOR 1; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SECRETASE; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ARTERY LIGATION; ARTICLE; ASSAY; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CYTOSOL; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMORAL ARTERY; GENE OVEREXPRESSION; IN VIVO STUDY; LUNG ENDOTHELIUM; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RETINA DEVELOPMENT; SIGNAL TRANSDUCTION; STIMULATION; WILD TYPE; ANIMAL; BLOOD FLOW; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; GENETICS; GENOTYPE; HINDLIMB; ISCHEMIA; KNOCKOUT MOUSE; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RETINA NEOVASCULARIZATION; SKELETAL MUSCLE; TIME FACTOR; VASCULARIZATION;

ADAM10 PROTEIN; ADAM17 PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENOTYPE; HINDLIMB; ISCHEMIA; MEMBRANE PROTEINS; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; PHENOTYPE; REACTIVE OXYGEN SPECIES; RECEPTORS, NOTCH; REGIONAL BLOOD FLOW; RETINAL NEOVASCULARIZATION; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84973537716     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307132     Document Type: Article

References (39)

1. Panieri E, Santoro MM. ROS signaling and redox biology in endothelial cells. Cell Mol Life Sci. 2015;72:3281-3303. doi: 10. 1007/ s00018-015-1928-9
2. Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee KH, Harrison DG, Tsao PS. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res. 2001;88:1291-1298
3. Swarnakar S, Paul S, Singh LP, Reiter RJ. Matrix metalloproteinases in health and disease: regulation by melatonin. J Pineal Res. 2011;50:8-20. doi: 10. 1111/j. 1600-079X. 2010. 00812. x
4. Brandes RP, Schröder K. Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases. Trends Cardiovasc Med. 2008;18:15-19. doi: 10. 1016/j. tcm. 2007. 11. 001
5. Brandes RP, Weissmann N, Schröder K. NADPH oxidases in cardiovascular disease. Free Radic Biol Med. 2010;49:687-706. doi: 10. 1016/j. freeradbiomed. 2010. 04. 030
6. Brandes RP, Weissmann N, Schröder K. Nox family NADPH oxidases in mechano-transduction: mechanisms and consequences. Antioxid Redox Signal. 2014;20:887-898. doi: 10. 1089/ars. 2013. 5414
7. Debbabi M, Kroviarski Y, Bournier O, Gougerot-Pocidalo MA, El-Benna J, Dang PM. NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1 assembly and activation. FASEB J. 2013;27:1733-1748. doi: 10. 1096/fj. 12-216432
8. Yamamoto A, Takeya R, Matsumoto M, Nakayama KI, Sumimoto H. Phosphorylation of Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1. FEBS J. 2013;280:5145-5159
9. Ambasta RK, Schreiber JG, Janiszewski M, Busse R, Brandes RP. Noxa1 is a central component of the smooth muscle NADPH oxidase in mice. Free Radic Biol Med. 2006;41:193-201. doi: 10. 1016/j. freeradbiomed. 2005. 12. 035
10. Niu XL, Madamanchi NR, Vendrov AE, Tchivilev I, Rojas M, Madamanchi C, Brandes RP, Krause KH, Humphries J, Smith A, Burnand KG, Runge MS. Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation. 2010;121:549-559. doi: 10. 1161/CIRCULATIONAHA. 109. 908319
11. Youn JY, Gao L, Cai H. The p47phox-and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Diabetologia. 2012;55:2069-2079. doi: 10. 1007/s00125-012-2557-6
12. Gao L, Cai H. Abstract 21188: Differential Roles of NOX1/NOXO1 and NOX2/p47phox Complexes in Endothelial Responses to Laminar and Oscillatory Shear Stress. Circulation. 2010;122:A21188
13. Bánfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, Krause KH. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem. 2004;279:46065-46072. doi: 10. 1074/jbc. M403046200
14. Kiss PJ, Knisz J, Zhang Y, Baltrusaitis J, Sigmund CD, Thalmann R, Smith RJ, Verpy E, Bánfi B. Inactivation of NADPH oxidase organizer 1 results in severe imbalance. Curr Biol. 2006;16:208-213. doi: 10. 1016/j. cub. 2005. 12. 025
15. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation. 2005;112:2677-2685. doi: 10. 1161/ CIRCULATIONAHA. 105. 573709
16. Garrido-Urbani S, Jemelin S, Deffert C, Carnesecchi S, Basset O, Szyndralewiez C, Heitz F, Page P, Montet X, Michalik L, Arbiser J, Rüegg C, Krause KH, Imhof BA, Imhof B. Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism. PLoS One. 2011;6:e14665. doi: 10. 1371/journal. pone. 0014665
17. Schröder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, Dimmeler S, Shah AM, Brandes RP. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res. 2012;110:1217-1225. doi: 10. 1161/ CIRCRESAHA. 112. 267054
18. Kovacic JC, Moore J, Herbert A, Ma D, Boehm M, Graham RM. Endothelial progenitor cells, angioblasts, and angiogenesis-old terms reconsidered from a current perspective. Trends Cardiovasc Med. 2008;18:45-51. doi: 10. 1016/j. tcm. 2007. 12. 002
19. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003;161:1163-1177. doi: 10. 1083/jcb. 200302047
20. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol. 1998;8:529-532
21. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell. 2002;3:411-423
22. Myers TJ, Brennaman LH, Stevenson M, Higashiyama S, Russell WE, Lee DC, Sunnarborg SW. Mitochondrial reactive oxygen species mediate GPCR-induced TACE/ADAM17-dependent transforming growth factoralpha shedding. Mol Biol Cell. 2009;20:5236-5249. doi: 10. 1091/mbc. E08-12-1256
23. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473:298-307. doi: 10. 1038/nature10144
24. Phng LK, Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev Cell. 2009;16:196-208. doi: 10. 1016/j. devcel. 2009. 01. 015
25. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black RA, Israël A. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell. 2000;5:207-216
26. Groot AJ, Vooijs MA. The role of Adams in Notch signaling. Adv Exp Med Biol. 2012;727:15-36. doi: 10. 1007/978-1-4614-0899-4-2
27. Kao H, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner CR, Evans RM, Kadesch T. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev. 1998;12:2269-2277
28. Cheng G, Lambeth JD. NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J Biol Chem. 2004;279:4737-4742. doi: 10. 1074/jbc. M305968200
29. Cheng G, Ritsick D, Lambeth JD. Nox3 regulation by NOXO1, p47phox, and p67phox. J Biol Chem. 2004;279:34250-34255. doi: 10. 1074/jbc. M400660200
30. Takeya R, Ueno N, Kami K, Taura M, Kohjima M, Izaki T, Nunoi H, Sumimoto H. Novel Human Homologues of p47phox and p67phox Participate in Activation of Superoxide-producing NADPH Oxidases. J. Biol. Chem. 2003;278:25234-25246
31. Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res. 2005;65:16-27. doi: 10. 1016/j. cardiores. 2004. 08. 007
32. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402:884-888. doi: 10. 1038/47260
33. Zhang Z, Oliver P, Lancaster JR, Schwarzenberger PO, Joshi MS, Cork J, Kolls JK. Reactive oxygen species mediate tumor necrosis factor alphaconverting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 2001;15:303-305
34. Wang Y, Herrera AH, Li Y, Belani KK, Walcheck B. Regulation of mature ADAM17 by redox agents for L-selectin shedding. J Immunol. 2009;182:2449-2457. doi: 10. 4049/jimmunol. 0802770
35. Helmcke I, Heumüller S, Tikkanen R, Schröder K, Brandes RP. Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxid Redox Signal. 2009;11:1279-1287. doi: 10. 1089/ars. 2008. 2383
36. Nelson KK, Melendez JA. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med. 2004;37:768-784. doi: 10. 1016/j. freeradbiomed. 2004. 06. 008
37. Li GG, Li L, Li C, Ye LY, Li XW, Liu DR, Bao Q, Zheng YX, Xiang DP, Chen L, Chen J. Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells. World J Gastroenterol. 2013;19:4486-4494. doi: 10. 3748/wjg. v19. i28. 4486
38. van Hinsbergh VW, Koolwijk P. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res. 2008;78:203-212. doi: 10. 1093/cvr/cvm102
39. Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, Lo WY, Wu TC, Sata M, Chen JW, Lin SJ. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrowderived endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2009;29:1179-1184. doi: 10. 1161/ATVBAHA. 109. 189175